Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Keurig Dr Pepper (KDP) Financials

Keurig Dr Pepper logo
$29.43 +0.50 (+1.73%)
Closing price 05/18/2026 04:00 PM Eastern
Extended Trading
$29.38 -0.04 (-0.15%)
As of 06:46 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Keurig Dr Pepper

Annual Income Statements for Keurig Dr Pepper

This table shows Keurig Dr Pepper's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/24/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
764 849 1,078 586 1,254 1,325 2,146 1,436 2,181 1,441 2,079
Consolidated Net Income / (Loss)
764 849 1,078 589 1,254 1,325 2,145 1,435 2,181 1,441 2,079
Net Income / (Loss) Continuing Operations
764 849 1,078 589 1,254 1,325 2,145 1,435 2,181 1,441 2,079
Total Pre-Tax Income
1,184 1,283 1,173 791 1,694 1,753 2,798 1,719 2,757 1,914 2,687
Total Operating Income
1,298 1,433 1,388 1,237 2,378 2,480 2,894 2,605 3,192 2,591 3,575
Total Gross Profit
3,723 3,858 3,995 3,882 6,342 6,486 6,977 7,323 8,080 8,529 8,999
Total Revenue
6,282 6,440 6,690 7,442 11,120 11,618 12,683 14,057 14,814 15,351 16,603
Operating Revenue
6,282 6,440 6,690 7,442 11,120 11,618 12,683 14,057 14,814 15,351 16,603
Total Cost of Revenue
2,559 2,582 2,695 3,560 4,778 5,132 5,706 6,734 6,734 6,822 7,604
Operating Cost of Revenue
2,559 2,582 2,695 3,560 4,778 5,132 5,706 6,734 6,734 6,822 7,604
Total Operating Expenses
2,425 2,425 2,607 2,645 3,964 4,006 4,083 4,718 4,888 5,938 5,424
Selling, General & Admin Expense
2,313 2,329 2,556 2,635 3,962 3,978 4,153 4,645 4,912 5,013 5,351
Other Operating Expenses / (Income)
7.00 -3.00 -51 10 2.00 -39 -70 -105 -26 207 -5.00
Impairment Charge
- - - 0.00 0.00 67 0.00 477 2.00 718 78
Total Other Income / (Expense), net
-114 -150 -215 -446 -684 -727 -96 -886 -435 -677 -888
Interest & Investment Income
2.00 3.00 3.00 - 0.00 0.00 524 -643 -496 -735 -754
Other Income / (Expense), net
1.00 25 8.00 19 -19 -119 -15 -26 61 58 -134
Income Tax Expense
420 434 95 202 440 428 653 284 576 473 608
Basic Earnings per Share
$4.00 $4.57 $5.91 $0.54 $0.89 $0.94 $1.52 $1.01 $1.56 $1.06 $1.53
Weighted Average Basic Shares Outstanding
190.90M 185.40M 182M 1.09B 1.41B 1.41B 1.42B 1.42B 1.40B 1.36B 1.36B
Diluted Earnings per Share
$3.97 $4.54 $5.89 $0.53 $0.88 $0.93 $1.50 $1.01 $1.55 $1.05 $1.53
Weighted Average Diluted Shares Outstanding
192.40M 186.60M 182.80M 1.10B 1.42B 1.42B 1.43B 1.43B 1.41B 1.37B 1.36B
Weighted Average Basic & Diluted Shares Outstanding
191M 183.09M 179.74M 1.09B 1.41B 1.41B 1.42B 1.41B 1.39B 1.36B 1.36B
Cash Dividends to Common per Share
$1.92 - $2.32 - $0.60 $0.60 $0.71 $0.78 $0.83 $0.89 $0.92

Quarterly Income Statements for Keurig Dr Pepper

This table shows Keurig Dr Pepper's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
518 693 454 515 616 -144 517 547 662 353 270
Consolidated Net Income / (Loss)
518 693 454 515 616 -144 517 547 662 353 270
Net Income / (Loss) Continuing Operations
518 693 454 515 616 -144 517 547 662 353 270
Total Pre-Tax Income
664 899 594 672 802 -154 660 718 852 457 357
Total Operating Income
896 943 765 861 902 63 801 898 995 881 756
Total Gross Profit
2,111 2,184 1,940 2,172 2,140 2,277 1,985 2,255 2,340 2,419 2,098
Total Revenue
3,805 3,867 3,468 3,922 3,891 4,070 3,635 4,163 4,306 4,499 3,976
Operating Revenue
3,805 3,867 3,468 3,922 3,891 4,070 3,635 4,163 4,306 4,499 3,976
Total Cost of Revenue
1,694 1,683 1,528 1,750 1,751 1,793 1,650 1,908 1,966 2,080 1,878
Operating Cost of Revenue
1,694 1,683 1,528 1,750 1,751 1,793 1,650 1,908 1,966 2,080 1,878
Total Operating Expenses
1,215 1,241 1,175 1,311 1,238 2,214 1,184 1,357 1,345 1,538 1,342
Selling, General & Admin Expense
1,217 1,258 1,176 1,295 1,245 1,297 1,192 1,356 1,344 1,459 1,342
Other Operating Expenses / (Income)
-4.00 -17 -1.00 16 -7.00 199 -8.00 1.00 1.00 1.00 0.00
Total Other Income / (Expense), net
-232 -44 -171 -189 -100 -217 -141 -180 -143 -424 -399
Interest Expense
237 -432 178 204 106 -488 148 180 188 - 281
Other Income / (Expense), net
5.00 20 7.00 15 6.00 30 7.00 0.00 45 -186 -118
Income Tax Expense
146 206 140 157 186 -10 143 171 190 104 87
Basic Earnings per Share
$0.37 $0.50 $0.33 $0.38 $0.45 ($0.10) $0.38 $0.40 $0.49 $0.26 $0.20
Weighted Average Basic Shares Outstanding
1.40B 1.40B 1.38B 1.36B 1.36B 1.36B 1.36B 1.36B 1.36B 1.36B 1.36B
Diluted Earnings per Share
$0.37 $0.49 $0.33 $0.38 $0.45 ($0.11) $0.38 $0.40 $0.49 $0.26 $0.20
Weighted Average Diluted Shares Outstanding
1.41B 1.41B 1.39B 1.36B 1.36B 1.37B 1.36B 1.36B 1.36B 1.36B 1.36B
Weighted Average Basic & Diluted Shares Outstanding
1.40B 1.39B 1.36B 1.36B 1.36B 1.36B 1.36B 1.36B 1.36B 1.36B 1.36B
Cash Dividends to Common per Share
$0.22 - $0.22 $0.22 - - $0.23 $0.23 - - $0.23

Annual Cash Flow Statements for Keurig Dr Pepper

This table details how cash moves in and out of Keurig Dr Pepper's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/24/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
683 880 -1,632 59 -40 150 322 -26 -287 382 419
Net Cash From Operating Activities
1,014 961 1,038 1,613 2,474 2,456 2,874 2,837 1,329 2,219 1,991
Net Cash From Continuing Operating Activities
1,014 961 1,038 1,613 2,474 2,456 2,874 2,837 1,329 2,219 1,991
Net Income / (Loss) Continuing Operations
764 847 1,076 589 1,254 1,325 2,146 1,436 2,181 1,441 2,079
Consolidated Net Income / (Loss)
764 847 1,076 589 1,254 1,325 2,146 1,436 2,181 1,441 2,079
Depreciation Expense
192 191 198 233 358 362 410 399 402 422 455
Amortization Expense
35 33 31 201 300 291 298 310 318 311 298
Non-Cash Adjustments To Reconcile Net Income
64 23 43 165 183 355 -292 873 148 799 118
Changes in Operating Assets and Liabilities, net
-41 -133 -310 425 379 123 312 -181 -1,720 -754 -959
Net Cash From Investing Activities
-194 -189 -1,763 -19,131 -150 -316 210 -1,135 -784 -1,614 -573
Net Cash From Continuing Investing Activities
-194 -189 -1,763 -19,131 -150 -316 210 -1,135 -784 -1,614 -573
Purchase of Property, Plant & Equipment
-179 -180 -202 -180 -330 -461 -423 -353 -425 -563 -486
Acquisitions
-21 -23 -1,565 -19,153 -59 -61 -32 -988 -372 -1,066 -167
Sale of Property, Plant & Equipment
20 6.00 3.00 3.00 247 203 122 168 9.00 4.00 14
Other Investing Activities, net
1.00 -8.00 -3.00 -5.00 -8.00 3.00 -35 -12 4.00 11 66
Net Cash From Financing Activities
-137 108 -907 17,577 -2,364 -1,990 -2,762 -1,728 -832 -223 -999
Net Cash From Continuing Financing Activities
-137 108 -907 17,577 -2,364 -1,990 -2,762 -1,728 -832 -223 -999
Repayment of Debt
-10 -911 -567 -5,398 -19,478 -11,589 -9,313 -3,161 -654 -1,782 -2,205
Repurchase of Common Equity
-521 -519 -399 - - 0.00 0.00 -379 -706 -1,110 -9.00
Payment of Dividends
-355 -386 -414 -214 -844 -846 -955 -1,080 -1,142 -1,194 -1,250
Issuance of Debt
751 1,950 482 14,206 18,527 10,638 7,556 3,000 1,827 4,039 2,625
Other Financing Activities, net
-2.00 -26 -9.00 -17 -569 -193 -190 -108 -157 -176 -160
Cash Interest Paid
- - - 231 521 515 477 363 443 494 594

Quarterly Cash Flow Statements for Keurig Dr Pepper

This table details how cash moves in and out of Keurig Dr Pepper's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-14 1.00 50 141 137 54 145 -192 2.00 464 17,822
Net Cash From Operating Activities
580 297 85 657 628 849 209 431 639 712 281
Net Cash From Continuing Operating Activities
580 297 85 657 628 849 209 431 639 712 281
Net Income / (Loss) Continuing Operations
518 693 454 515 616 -144 517 547 662 353 270
Consolidated Net Income / (Loss)
518 693 454 515 616 -144 517 547 662 353 270
Depreciation Expense
98 103 101 106 103 112 106 111 119 119 114
Amortization Expense
79 79 69 99 72 71 60 74 87 80 169
Non-Cash Adjustments To Reconcile Net Income
178 -44 12 82 11 694 -60 16 -50 209 -1.00
Changes in Operating Assets and Liabilities, net
-293 -534 -551 -145 -174 116 -414 -317 -179 -49 -271
Net Cash From Investing Activities
-420 -161 -193 -136 -209 -1,076 -57 -221 -112 -183 -98
Net Cash From Continuing Investing Activities
-420 -161 -193 -136 -209 -1,076 -57 -221 -112 -183 -98
Purchase of Property, Plant & Equipment
-122 -154 -158 -115 -125 -165 -120 -106 -112 -148 -116
Acquisitions
-300 -9.00 -37 -19 -85 -925 -14 -114 -3.00 -36 -2.00
Sale of Property, Plant & Equipment
1.00 - 0.00 1.00 - 3.00 13 - 1.00 - 19
Other Investing Activities, net
1.00 2.00 2.00 -3.00 1.00 11 64 -1.00 2.00 1.00 1.00
Net Cash From Financing Activities
-174 -135 158 -380 -282 281 -7.00 -402 -525 -65 17,639
Net Cash From Continuing Financing Activities
-174 -135 158 -380 -282 281 -7.00 -402 -525 -65 17,639
Repayment of Debt
125 549 -1,389 -69 44 241 345 -2,045 -186 -319 -38
Payment of Dividends
-279 -300 -299 -292 -292 -311 -312 -313 -312 -313 -312
Issuance of Debt
30 -91 3,023 8.00 8.00 471 8.00 2,008 7.00 602 5,985
Issuance of Preferred Equity
- - - - - - - - - - 4,489
Other Financing Activities, net
-50 -44 -72 -27 -42 -115 -48 -43 -34 -35 7,515
Cash Interest Paid
24 188 24 187 97 186 93 184 100 217 97

Annual Balance Sheets for Keurig Dr Pepper

This table presents Keurig Dr Pepper's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/24/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
8,869 9,791 15,744 48,918 49,518 49,779 50,598 51,837 52,130 53,430 55,459
Total Current Assets
1,817 2,736 1,056 2,159 2,273 2,388 3,057 3,804 3,375 3,997 5,266
Cash & Equivalents
911 1,787 90 83 75 240 567 535 267 510 1,026
Restricted Cash
- 0.00 5.00 46 26 15 1.00 - 0.00 80 18
Accounts Receivable
628 646 483 1,150 1,115 1,048 1,148 1,484 1,368 1,502 1,671
Inventories, net
209 202 384 626 654 762 894 1,314 1,142 1,299 1,733
Prepaid Expenses
69 101 94 254 403 323 447 471 598 606 818
Plant, Property, & Equipment, net
1,156 1,138 790 2,310 2,028 2,212 2,494 2,491 2,699 2,964 3,230
Total Noncurrent Assets
5,896 5,917 13,898 44,449 45,217 45,179 45,047 45,542 46,056 46,469 46,963
Long-Term Investments
31 23 97 186 151 88 30 1,000 1,387 1,543 1,660
Goodwill
2,988 2,993 9,819 20,011 20,172 20,184 20,182 20,072 20,202 20,053 20,247
Intangible Assets
2,663 2,656 3,834 23,967 24,117 23,968 23,856 23,183 23,287 23,634 23,725
Noncurrent Deferred & Refundable Income Taxes
64 62 27 26 29 45 42 35 31 39 36
Other Noncurrent Operating Assets
150 183 121 259 748 894 937 1,252 1,149 1,200 1,295
Total Liabilities & Shareholders' Equity
8,869 9,791 15,744 48,918 49,518 49,779 50,598 51,837 52,130 53,430 55,459
Total Liabilities
6,686 7,657 8,081 26,385 26,261 25,949 25,626 26,712 26,454 29,187 29,943
Total Current Liabilities
1,583 1,051 2,018 5,702 6,474 7,694 6,485 8,076 8,916 8,087 8,290
Short-Term Debt
507 10 225 1,458 1,593 2,345 304 895 3,246 2,642 3,105
Accounts Payable
277 303 1,580 2,300 3,176 3,740 4,316 5,206 3,597 2,985 2,996
Accrued Expenses
708 670 201 1,012 939 1,040 1,110 1,153 1,242 1,584 1,379
Other Current Liabilities
- - 12 932 766 569 755 822 831 876 810
Total Noncurrent Liabilities
5,103 6,606 6,063 20,683 19,787 18,255 19,141 18,636 17,538 21,100 21,653
Long-Term Debt
2,875 4,468 3,064 14,201 12,827 11,143 11,578 11,072 9,945 12,912 13,036
Noncurrent Deferred & Payable Income Tax Liabilities
787 812 1,031 5,923 6,030 5,993 5,986 5,739 5,760 5,435 5,526
Other Noncurrent Operating Liabilities
260 209 1,871 559 930 1,119 1,577 1,825 1,833 2,753 3,091
Redeemable Noncontrolling Interest
- - 265 - - - - - - - 0.00
Total Equity & Noncontrolling Interests
2,183 2,134 7,398 22,533 23,257 23,830 24,972 25,125 25,676 24,243 25,516
Total Preferred & Common Equity
2,183 2,134 7,398 22,533 23,257 23,829 24,972 25,126 25,676 24,243 25,516
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
2,183 2,134 7,398 22,533 23,257 23,829 24,972 25,126 25,676 24,243 25,521
Common Stock
213 97 6,385 21,485 21,571 21,691 21,799 21,458 20,802 19,726 19,797
Retained Earnings
2,165 2,266 914 1,178 1,582 2,061 3,199 3,539 4,559 4,793 5,622
Accumulated Other Comprehensive Income / (Loss)
-195 -229 99 -130 104 77 -26 129 315 -276 102
Noncontrolling Interest
- - - - 0.00 1.00 0.00 -1.00 0.00 0.00 0.00

Quarterly Balance Sheets for Keurig Dr Pepper

This table presents Keurig Dr Pepper's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
51,801 51,763 52,130 52,286 52,344 52,718 53,430 53,699 54,368 54,605 73,140
Total Current Assets
3,570 3,406 3,375 3,567 3,819 4,102 3,997 4,346 4,606 4,701 23,132
Cash & Equivalents
278 260 267 317 438 552 510 653 509 516 898
Restricted Cash
- - 0.00 - - 8.00 80 80 56 53 17,818
Accounts Receivable
1,311 1,279 1,368 1,311 1,390 1,448 1,502 1,329 1,498 1,497 1,539
Inventories, net
1,384 1,348 1,142 1,204 1,252 1,351 1,299 1,539 1,741 1,840 1,829
Prepaid Expenses
597 519 598 735 739 743 606 745 802 795 1,048
Plant, Property, & Equipment, net
2,489 2,527 2,699 2,695 2,680 2,794 2,964 2,951 2,996 3,039 3,249
Total Noncurrent Assets
45,742 45,830 46,056 46,024 45,845 45,822 46,469 46,402 46,766 46,865 46,759
Long-Term Investments
1,019 1,336 1,387 1,438 1,468 1,492 1,543 1,568 1,566 1,617 1,703
Goodwill
20,194 20,122 20,202 20,163 20,081 20,078 20,053 20,062 20,228 20,198 20,210
Intangible Assets
23,344 23,223 23,287 23,251 23,108 23,072 23,634 23,616 23,841 23,786 23,653
Noncurrent Deferred & Refundable Income Taxes
32 32 31 44 44 41 39 40 36 36 17
Other Noncurrent Operating Assets
1,153 1,117 1,149 1,128 1,144 1,139 1,200 1,116 1,095 1,228 1,176
Total Liabilities & Shareholders' Equity
51,801 51,763 52,130 52,286 52,344 52,718 53,430 53,699 54,368 54,605 73,140
Total Liabilities
26,534 26,399 26,454 27,633 27,626 27,749 29,187 29,252 29,383 29,281 39,540
Total Current Liabilities
9,056 8,814 8,916 7,004 7,509 7,699 8,087 9,171 7,221 7,527 10,025
Short-Term Debt
2,635 2,798 3,246 1,908 2,399 2,472 2,642 3,999 1,976 2,285 4,816
Accounts Payable
4,601 4,090 3,597 3,187 3,099 3,133 2,985 3,154 3,113 2,993 2,843
Accrued Expenses
1,030 1,123 1,242 1,169 1,302 1,288 1,584 1,201 1,324 1,396 1,466
Other Current Liabilities
790 803 831 740 709 806 876 817 808 853 900
Total Noncurrent Liabilities
17,478 17,585 17,538 20,629 20,117 20,050 21,100 20,081 22,162 21,754 29,515
Long-Term Debt
9,934 9,940 9,945 12,929 12,406 12,413 12,912 11,927 13,920 13,531 20,891
Noncurrent Deferred & Payable Income Tax Liabilities
5,736 5,714 5,760 5,784 5,746 5,736 5,435 5,430 5,487 5,433 5,467
Other Noncurrent Operating Liabilities
1,808 1,931 1,833 1,916 1,965 1,901 2,753 2,724 2,755 2,790 3,157
Redeemable Noncontrolling Interest
- - - - - - - - - - 4,418
Total Equity & Noncontrolling Interests
25,267 25,364 25,676 0.00 24,718 24,969 24,243 24,447 24,985 25,324 29,182
Total Preferred & Common Equity
25,268 25,364 25,676 24,653 24,718 24,969 24,243 24,447 24,985 25,324 25,261
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
25,268 25,364 25,676 24,653 24,718 24,969 24,243 24,447 24,985 25,324 25,266
Common Stock
21,023 21,028 20,802 19,675 19,697 19,706 19,726 19,725 19,743 19,767 19,802
Retained Earnings
3,948 4,165 4,559 4,721 4,944 5,249 4,793 4,997 5,232 5,581 5,580
Accumulated Other Comprehensive Income / (Loss)
297 171 315 257 77 14 -276 -275 10 -24 -116
Noncontrolling Interest
-1.00 0.00 0.00 0.00 0.00 0.00 0.00 - - - 3,921

Annual Metrics And Ratios for Keurig Dr Pepper

This table displays calculated financial ratios and metrics derived from Keurig Dr Pepper's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/24/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
2.63% 2.52% 3.88% 11.24% 49.42% 4.48% 9.17% 10.83% 5.39% 3.62% 8.16%
EBITDA Growth
7.84% 10.22% -3.39% 4.00% 78.52% -0.10% 19.01% -8.34% 20.83% -14.88% 24.01%
EBIT Growth
10.08% 12.24% -4.25% -10.03% 87.82% 0.08% 21.94% -10.42% 26.13% -18.57% 29.90%
NOPAT Growth
8.49% 13.22% 34.52% -27.79% 91.11% 6.49% 18.36% -1.98% 16.12% -22.75% 41.80%
Net Income Growth
8.68% 11.13% 26.97% -45.36% 112.90% 5.66% 61.89% -33.10% 51.99% -33.93% 44.27%
EPS Growth
11.52% 14.36% 29.74% -91.00% 66.04% 5.68% 61.29% -32.67% 53.47% -32.26% 45.71%
Operating Cash Flow Growth
-0.78% -5.23% 8.01% 55.40% 53.38% -0.73% 17.02% -1.29% -53.15% 66.97% -10.27%
Free Cash Flow Firm Growth
1.39% -8.48% -721.30% -446.07% 108.48% 5.07% 26.38% -2.18% -69.76% 72.55% -1.51%
Invested Capital Growth
-0.06% 3.87% 126.09% 248.87% -1.19% -1.20% -1.94% -1.93% 4.66% 1.21% 3.42%
Revenue Q/Q Growth
0.59% 0.50% 11.04% 8.29% 1.10% 1.64% 2.18% 3.02% 0.43% 1.34% 2.65%
EBITDA Q/Q Growth
4.38% 0.60% 3.97% 8.13% 6.68% 0.00% 0.62% -0.87% 7.73% -20.44% 17.28%
EBIT Q/Q Growth
5.35% 0.76% 14.90% 1.78% 7.82% -0.21% 0.00% -0.88% 9.49% -24.72% 21.20%
NOPAT Q/Q Growth
4.73% 1.32% 51.47% -22.38% 7.30% 0.70% 0.44% 1.80% 7.57% -26.80% 31.66%
Net Income Q/Q Growth
4.80% -2.08% 66.10% -35.91% 12.57% 1.69% 23.99% -21.37% 12.36% -36.74% 31.42%
EPS Q/Q Growth
5.59% -1.52% 95.03% -87.04% 10.00% 1.09% 23.97% -21.09% 12.32% -36.36% 31.90%
Operating Cash Flow Q/Q Growth
3.89% -3.51% -34.18% 106.79% 5.14% 5.09% 5.55% -6.65% -24.96% 33.11% -6.44%
Free Cash Flow Firm Q/Q Growth
1.42% 6.71% 29.14% -5.34% -9.43% -8.47% 30.86% -13.45% -42.04% 9.55% 55.65%
Invested Capital Q/Q Growth
0.63% -0.15% -12.42% -1.25% -0.35% 0.26% -1.59% -0.28% 1.94% -0.37% 0.00%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
59.26% 59.91% 59.72% 52.16% 57.03% 55.83% 55.01% 52.10% 54.54% 55.56% 54.20%
EBITDA Margin
24.29% 26.12% 24.29% 22.71% 27.13% 25.94% 28.28% 23.39% 26.82% 22.03% 25.26%
Operating Margin
20.66% 22.25% 20.75% 16.62% 21.38% 21.35% 22.82% 18.53% 21.55% 16.88% 21.53%
EBIT Margin
20.68% 22.64% 20.87% 16.88% 21.21% 20.32% 22.70% 18.35% 21.96% 17.26% 20.73%
Profit (Net Income) Margin
12.16% 13.18% 16.11% 7.91% 11.28% 11.40% 16.91% 10.21% 14.72% 9.39% 12.52%
Tax Burden Percent
64.53% 66.17% 91.90% 74.46% 74.03% 75.58% 76.66% 83.48% 79.11% 75.29% 77.37%
Interest Burden Percent
91.15% 88.00% 84.03% 62.98% 71.81% 74.25% 97.19% 66.65% 84.75% 72.25% 78.09%
Effective Tax Rate
35.47% 33.83% 8.10% 25.54% 25.97% 24.42% 23.34% 16.52% 20.89% 24.71% 22.63%
Return on Invested Capital (ROIC)
18.11% 20.12% 16.29% 3.78% 4.68% 5.04% 6.06% 6.06% 6.94% 5.21% 7.22%
ROIC Less NNEP Spread (ROIC-NNEP)
15.03% 16.24% 9.55% 0.20% 1.24% 1.02% 5.46% -0.76% 3.81% 1.13% 2.10%
Return on Net Nonoperating Assets (RNNOA)
16.02% 19.21% 5.71% 0.12% 0.80% 0.59% 2.73% -0.33% 1.65% 0.56% 1.14%
Return on Equity (ROE)
34.13% 39.33% 22.01% 3.90% 5.48% 5.63% 8.79% 5.73% 8.59% 5.77% 8.36%
Cash Return on Invested Capital (CROIC)
18.18% 16.32% -61.04% -107.11% 5.88% 6.25% 8.02% 8.00% 2.39% 4.01% 3.86%
Operating Return on Assets (OROA)
15.16% 15.63% 10.93% 3.88% 4.79% 4.76% 5.74% 5.04% 6.26% 5.02% 6.32%
Return on Assets (ROA)
8.92% 9.10% 8.44% 1.82% 2.55% 2.67% 4.27% 2.80% 4.20% 2.73% 3.82%
Return on Common Equity (ROCE)
34.13% 39.33% 21.41% 3.87% 5.48% 5.63% 8.79% 5.73% 8.59% 5.77% 8.36%
Return on Equity Simple (ROE_SIMPLE)
35.00% 39.78% 14.57% 2.61% 5.39% 5.56% 8.59% 5.71% 8.49% 5.94% 0.00%
Net Operating Profit after Tax (NOPAT)
838 948 1,276 921 1,760 1,875 2,219 2,175 2,525 1,951 2,766
NOPAT Margin
13.33% 14.72% 19.07% 12.38% 15.83% 16.13% 17.49% 15.47% 17.05% 12.71% 16.66%
Net Nonoperating Expense Percent (NNEP)
3.08% 3.89% 6.74% 3.58% 3.43% 4.02% 0.60% 6.81% 3.13% 4.08% 5.12%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 5.86% 6.50% 4.90% 6.64%
Cost of Revenue to Revenue
40.74% 40.09% 40.28% 47.84% 42.97% 44.17% 44.99% 47.91% 45.46% 44.44% 45.80%
SG&A Expenses to Revenue
36.82% 36.16% 38.21% 35.41% 35.63% 34.24% 32.74% 33.04% 33.16% 32.66% 32.23%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
38.60% 37.66% 38.97% 35.54% 35.65% 34.48% 32.19% 33.56% 33.00% 38.68% 32.67%
Earnings before Interest and Taxes (EBIT)
1,299 1,458 1,396 1,256 2,359 2,361 2,879 2,579 3,253 2,649 3,441
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,526 1,682 1,625 1,690 3,017 3,014 3,587 3,288 3,973 3,382 4,194
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.07 1.07 0.33 1.39 1.57 1.74 1.96 1.90 1.76 1.78 1.48
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.37 0.35 0.37 4.20 3.29 3.56 3.86 3.39 3.04 2.82 2.27
Price to Earnings (P/E)
3.07 2.68 2.27 53.40 29.17 31.21 22.82 33.19 20.66 30.02 18.15
Dividend Yield
15.46% 17.12% 17.09% 466.36% 2.31% 2.04% 1.95% 2.27% 2.53% 2.74% 3.31%
Earnings Yield
32.57% 37.32% 43.99% 1.87% 3.43% 3.20% 4.38% 3.01% 4.84% 3.33% 5.51%
Enterprise Value to Invested Capital (EV/IC)
1.04 1.03 0.54 1.23 1.36 1.47 1.66 1.63 1.52 1.50 1.31
Enterprise Value to Revenue (EV/Rev)
0.76 0.77 0.88 6.27 4.56 4.69 4.75 4.13 3.82 3.69 3.08
Enterprise Value to EBITDA (EV/EBITDA)
3.14 2.94 3.64 27.60 16.82 18.08 16.80 17.67 14.25 16.76 12.20
Enterprise Value to EBIT (EV/EBIT)
3.68 3.39 4.23 37.13 21.51 23.09 20.93 22.52 17.40 21.39 14.87
Enterprise Value to NOPAT (EV/NOPAT)
5.71 5.21 4.63 50.63 28.83 29.08 27.16 26.71 22.41 29.05 18.50
Enterprise Value to Operating Cash Flow (EV/OCF)
4.72 5.14 5.69 28.91 20.51 22.19 20.96 20.48 42.59 25.54 25.70
Enterprise Value to Free Cash Flow (EV/FCFF)
5.69 6.43 0.00 0.00 22.94 23.45 20.51 20.22 65.12 37.79 34.65
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.55 2.10 0.44 0.69 0.62 0.57 0.48 0.48 0.51 0.64 0.63
Long-Term Debt to Equity
1.32 2.09 0.41 0.63 0.55 0.47 0.46 0.44 0.39 0.53 0.51
Financial Leverage
1.07 1.18 0.60 0.61 0.64 0.58 0.50 0.43 0.43 0.50 0.54
Leverage Ratio
3.83 4.32 2.61 2.14 2.15 2.11 2.06 2.04 2.05 2.11 2.19
Compound Leverage Factor
3.49 3.80 2.19 1.35 1.54 1.57 2.00 1.36 1.73 1.53 1.71
Debt to Total Capital
60.77% 67.73% 30.65% 41.00% 38.27% 36.14% 32.24% 32.26% 33.94% 39.08% 38.75%
Short-Term Debt to Total Capital
9.11% 0.15% 2.04% 3.82% 4.23% 6.28% 0.82% 2.41% 8.35% 6.64% 7.45%
Long-Term Debt to Total Capital
51.66% 67.57% 28.61% 37.18% 34.04% 29.86% 31.42% 29.85% 25.59% 32.44% 31.29%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 2.40% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
39.23% 32.27% 66.96% 59.00% 61.73% 63.85% 67.76% 67.74% 66.06% 60.92% 61.25%
Debt to EBITDA
2.22 2.66 2.08 9.27 4.78 4.48 3.31 3.64 3.32 4.60 3.85
Net Debt to EBITDA
1.60 1.59 1.97 9.08 4.70 4.36 3.15 3.17 2.90 3.97 3.20
Long-Term Debt to EBITDA
1.88 2.66 1.95 8.40 4.25 3.70 3.23 3.37 2.50 3.82 3.11
Debt to NOPAT
4.04 4.72 2.65 17.00 8.19 7.20 5.36 5.50 5.22 7.97 5.84
Net Debt to NOPAT
2.91 2.81 2.50 16.66 8.05 7.01 5.09 4.80 4.57 6.88 4.86
Long-Term Debt to NOPAT
3.43 4.71 2.48 15.42 7.29 5.94 5.22 5.09 3.94 6.62 4.71
Altman Z-Score
1.78 1.86 0.91 0.90 1.16 1.28 1.59 1.50 1.51 1.37 1.34
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 2.70% 0.88% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.15 2.60 0.52 0.38 0.35 0.31 0.47 0.47 0.38 0.49 0.64
Quick Ratio
0.97 2.31 0.28 0.22 0.18 0.17 0.26 0.25 0.18 0.25 0.33
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
841 769 -4,779 -26,099 2,212 2,325 2,938 2,874 869 1,500 1,477
Operating Cash Flow to CapEx
637.74% 552.30% 521.61% 911.30% 2,980.72% 951.94% 954.82% 1,533.51% 319.47% 396.96% 421.82%
Free Cash Flow to Firm to Interest Expense
7.18 4.32 -21.15 -56.13 3.33 3.82 4.86 13.24 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
8.67 5.40 4.59 3.47 3.72 4.04 4.75 13.07 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
7.31 4.42 3.71 3.09 3.60 3.62 4.25 12.22 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.73 0.69 0.52 0.23 0.23 0.23 0.25 0.27 0.29 0.29 0.31
Accounts Receivable Turnover
10.09 10.11 11.85 9.11 9.82 10.74 11.55 10.68 10.39 10.70 10.47
Inventory Turnover
12.39 12.56 9.20 7.05 7.47 7.25 6.89 6.10 5.48 5.59 5.02
Fixed Asset Turnover
5.47 5.61 6.94 4.80 5.13 5.48 5.39 5.64 5.71 5.42 5.36
Accounts Payable Turnover
9.04 8.90 2.86 1.84 1.75 1.48 1.42 1.41 1.53 2.07 2.54
Days Sales Outstanding (DSO)
36.17 36.10 30.80 40.05 37.17 33.98 31.60 34.17 35.14 34.12 34.88
Days Inventory Outstanding (DIO)
29.45 29.05 39.68 51.78 48.89 50.35 52.97 59.84 66.56 65.30 72.77
Days Payable Outstanding (DPO)
40.37 41.00 127.51 198.90 209.16 245.94 257.66 258.06 238.57 176.08 143.55
Cash Conversion Cycle (CCC)
25.26 24.16 -57.03 -107.08 -123.10 -161.61 -173.10 -164.05 -136.88 -76.66 -35.90
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
4,623 4,802 10,857 37,877 37,425 36,975 36,256 35,557 37,213 37,664 38,953
Invested Capital Turnover
1.36 1.37 0.85 0.31 0.30 0.31 0.35 0.39 0.41 0.41 0.43
Increase / (Decrease) in Invested Capital
-3.00 179 6,055 27,020 -452 -450 -719 -699 1,656 451 1,289
Enterprise Value (EV)
4,786 4,943 5,910 46,637 50,748 54,506 60,248 58,091 56,600 56,675 51,178
Market Capitalization
2,346 2,275 2,451 31,293 36,580 41,360 48,964 47,660 45,063 43,254 37,741
Book Value per Share
$11.56 $11.62 $40.98 $16.22 $16.53 $16.93 $17.61 $17.74 $18.36 $17.87 $18.78
Tangible Book Value per Share
($18.36) ($19.13) ($34.65) ($15.44) ($14.95) ($14.44) ($13.45) ($12.80) ($12.74) ($14.33) ($13.58)
Total Capital
5,565 6,612 11,049 38,192 37,677 37,318 36,854 37,092 38,867 39,797 41,657
Total Debt
3,382 4,478 3,386 15,659 14,420 13,488 11,882 11,967 13,191 15,554 16,141
Total Long-Term Debt
2,875 4,468 3,161 14,201 12,827 11,143 11,578 11,072 9,945 12,912 13,036
Net Debt
2,440 2,668 3,194 15,344 14,168 13,145 11,284 10,432 11,537 13,421 13,437
Capital Expenditures (CapEx)
159 174 199 177 83 258 301 185 416 559 472
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-170 -92 -832 -2,214 -2,709 -3,216 -3,692 -3,912 -2,562 -2,038 -963
Debt-free Net Working Capital (DFNWC)
741 1,695 -737 -2,085 -2,608 -2,961 -3,124 -3,377 -2,295 -1,448 81
Net Working Capital (NWC)
234 1,685 -962 -3,543 -4,201 -5,306 -3,428 -4,272 -5,541 -4,090 -3,024
Net Nonoperating Expense (NNE)
74 99 198 332 506 550 74 740 344 510 687
Net Nonoperating Obligations (NNO)
2,440 2,668 3,194 15,344 14,168 13,145 11,284 10,432 11,537 13,421 13,437
Total Depreciation and Amortization (D&A)
227 224 229 434 658 653 708 709 720 733 753
Debt-free, Cash-free Net Working Capital to Revenue
-2.71% -1.43% -12.44% -29.75% -24.36% -27.68% -29.11% -27.83% -17.29% -13.28% -5.80%
Debt-free Net Working Capital to Revenue
11.80% 26.32% -11.02% -28.02% -23.45% -25.49% -24.63% -24.02% -15.49% -9.43% 0.49%
Net Working Capital to Revenue
3.72% 26.16% -14.38% -47.61% -37.78% -45.67% -27.03% -30.39% -37.40% -26.64% -18.21%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$4.00 $4.57 $5.91 $0.54 $0.89 $0.94 $1.52 $1.01 $1.56 $1.06 $1.53
Adjusted Weighted Average Basic Shares Outstanding
190.90M 185.40M 182M 1.09B 1.41B 1.41B 1.42B 1.42B 1.40B 1.36B 1.36B
Adjusted Diluted Earnings per Share
$3.97 $4.54 $5.89 $0.53 $0.88 $0.93 $1.50 $1.01 $1.55 $1.05 $1.53
Adjusted Weighted Average Diluted Shares Outstanding
192.40M 186.60M 182.80M 1.10B 1.42B 1.42B 1.43B 1.43B 1.41B 1.37B 1.36B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $5.91 $0.54 $0.89 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
187.35M 183.09M 179.74M 1.41B 1.41B 1.41B 1.42B 1.41B 1.39B 1.36B 1.36B
Normalized Net Operating Profit after Tax (NOPAT)
838 948 1,276 921 1,760 1,925 2,219 2,323 2,527 2,491 2,826
Normalized NOPAT Margin
13.33% 14.72% 19.07% 12.38% 15.83% 16.57% 17.49% 16.53% 17.06% 16.23% 17.02%
Pre Tax Income Margin
18.85% 19.92% 17.53% 10.63% 15.23% 15.09% 22.06% 12.23% 18.61% 12.47% 16.18%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
11.10 8.19 6.18 2.70 3.55 3.88 4.76 11.88 0.00 0.00 0.00
NOPAT to Interest Expense
7.16 5.33 5.64 1.98 2.65 3.08 3.67 10.02 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
9.74 7.21 5.30 2.32 3.42 3.46 4.26 11.03 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
5.80 4.35 4.76 1.60 2.52 2.66 3.17 9.17 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
46.47% 45.47% 38.40% 36.33% 67.30% 63.85% 44.52% 75.26% 52.36% 82.86% 60.13%
Augmented Payout Ratio
114.66% 106.60% 75.42% 36.33% 67.30% 63.85% 44.52% 101.67% 84.73% 159.89% 60.56%

Quarterly Metrics And Ratios for Keurig Dr Pepper

This table displays calculated financial ratios and metrics derived from Keurig Dr Pepper's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 1,358,666,059.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 1,358,666,059.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.20
Growth Metrics
- - - - - - - - - - -
Revenue Growth
5.05% 1.68% 3.43% 3.51% 2.26% 5.25% 4.82% 6.14% 10.67% 10.54% 9.38%
EBITDA Growth
91.81% 33.14% 19.24% 12.60% 0.46% -75.90% 3.08% 0.19% 15.05% 223.91% -5.44%
EBIT Growth
131.03% 41.41% 27.81% 11.59% 0.78% -90.34% 4.66% 2.51% 14.54% 647.31% -21.04%
NOPAT Growth
81.37% 33.05% 24.56% 4.57% -0.88% -93.93% 7.31% 3.68% 11.59% 1,443.11% -8.87%
Net Income Growth
189.39% 52.98% -2.78% 2.39% 18.92% -120.78% 13.88% 6.21% 7.47% 345.14% -47.78%
EPS Growth
184.62% 53.13% 0.00% 5.56% 21.62% -122.45% 15.15% 5.26% 8.89% 336.36% -47.37%
Operating Cash Flow Growth
-23.58% -59.81% 19.72% 72.44% 8.28% 185.86% 145.88% -34.40% 1.75% -16.14% 34.45%
Free Cash Flow Firm Growth
-109.49% -174.60% -225.68% -202.99% -304.79% 56.20% 128.41% -7.34% 37.19% -49.54% -184.09%
Invested Capital Growth
2.38% 4.66% 4.45% 2.95% 3.55% 1.21% 0.89% 3.01% 3.05% 3.42% 2.14%
Revenue Q/Q Growth
0.42% 1.63% -10.32% 13.09% -0.79% 4.60% -10.69% 14.53% 3.44% 4.48% -11.62%
EBITDA Q/Q Growth
12.29% 6.22% -17.73% 14.76% 0.19% -74.52% 251.81% 11.53% 15.05% -28.25% 3.02%
EBIT Q/Q Growth
14.78% 6.88% -19.83% 13.47% 3.65% -89.76% 768.82% 11.14% 15.81% -33.17% -8.20%
NOPAT Q/Q Growth
10.77% 4.00% -19.56% 12.85% 5.00% -93.63% 1,322.79% 9.03% 13.01% -11.98% -15.98%
Net Income Q/Q Growth
2.98% 33.78% -34.49% 13.44% 19.61% -123.38% 459.03% 5.80% 21.02% -46.68% -23.51%
EPS Q/Q Growth
2.78% 32.43% -32.65% 15.15% 18.42% -124.44% 445.45% 5.26% 22.50% -46.94% -23.08%
Operating Cash Flow Q/Q Growth
52.23% -48.79% -71.38% 672.94% -4.41% 35.19% -75.38% 106.22% 48.26% 11.42% -60.53%
Free Cash Flow Firm Q/Q Growth
-136.70% -523.49% -10.03% 59.10% -44.25% 32.54% 171.38% -254.54% 15.59% -60.60% 59.86%
Invested Capital Q/Q Growth
-0.09% 1.94% 1.40% -0.31% 0.49% -0.37% 1.08% 1.78% 0.53% 0.00% -0.17%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
55.48% 56.48% 55.94% 55.38% 55.00% 55.95% 54.61% 54.17% 54.34% 53.77% 52.77%
EBITDA Margin
28.33% 29.61% 27.16% 27.56% 27.83% 6.78% 26.71% 26.01% 28.94% 19.87% 23.16%
Operating Margin
23.55% 24.39% 22.06% 21.95% 23.18% 1.55% 22.04% 21.57% 23.11% 19.58% 19.01%
EBIT Margin
23.68% 24.90% 22.26% 22.34% 23.34% 2.29% 22.23% 21.57% 24.15% 15.45% 16.05%
Profit (Net Income) Margin
13.61% 17.92% 13.09% 13.13% 15.83% -3.54% 14.22% 13.14% 15.37% 7.85% 6.79%
Tax Burden Percent
78.01% 77.09% 76.43% 76.64% 76.81% 93.51% 78.33% 76.18% 77.70% 77.24% 75.63%
Interest Burden Percent
73.70% 93.35% 76.94% 76.71% 88.33% -165.59% 81.68% 79.96% 81.92% 65.76% 55.96%
Effective Tax Rate
21.99% 22.91% 23.57% 23.36% 23.19% 0.00% 21.67% 23.82% 22.30% 22.76% 24.37%
Return on Invested Capital (ROIC)
7.51% 7.65% 6.82% 6.83% 7.26% 0.44% 7.07% 6.78% 7.57% 6.56% 6.33%
ROIC Less NNEP Spread (ROIC-NNEP)
5.84% 7.34% 6.28% 5.64% 6.62% -1.06% 6.64% 5.75% 6.73% 4.12% 3.14%
Return on Net Nonoperating Assets (RNNOA)
2.51% 3.18% 12.20% 2.73% 3.15% -0.53% 13.94% 3.09% 3.54% 2.22% 1.02%
Return on Equity (ROE)
10.02% 10.83% 19.01% 9.56% 10.41% -0.09% 21.01% 9.87% 11.11% 8.78% 7.36%
Cash Return on Invested Capital (CROIC)
4.16% 2.39% 2.80% 4.29% 3.68% 4.01% 4.38% 2.32% 2.47% 3.86% 4.93%
Operating Return on Assets (OROA)
6.77% 7.10% 6.39% 6.46% 6.77% 0.66% 6.51% 6.37% 7.28% 4.71% 4.29%
Return on Assets (ROA)
3.89% 5.11% 3.76% 3.80% 4.59% -1.03% 4.16% 3.88% 4.63% 2.39% 1.81%
Return on Common Equity (ROCE)
10.02% 10.83% 37.69% 9.56% 10.41% -0.09% 42.20% 9.87% 11.11% 8.78% 6.30%
Return on Equity Simple (ROE_SIMPLE)
7.65% 0.00% 8.79% 8.82% 9.12% 0.00% 6.15% 6.15% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
699 727 585 660 693 44 627 684 773 681 572
NOPAT Margin
18.37% 18.80% 16.86% 16.82% 17.81% 1.08% 17.26% 16.43% 17.95% 15.13% 14.38%
Net Nonoperating Expense Percent (NNEP)
1.67% 0.31% 0.54% 1.20% 0.64% 1.51% 0.43% 1.03% 0.84% 2.44% 3.19%
Return On Investment Capital (ROIC_SIMPLE)
- 1.87% - - - 0.11% 1.55% 1.67% 1.88% 1.63% 1.04%
Cost of Revenue to Revenue
44.52% 43.52% 44.06% 44.62% 45.00% 44.05% 45.39% 45.83% 45.66% 46.23% 47.23%
SG&A Expenses to Revenue
31.98% 32.53% 33.91% 33.02% 32.00% 31.87% 32.79% 32.57% 31.21% 32.43% 33.75%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
31.93% 32.09% 33.88% 33.43% 31.82% 54.40% 32.57% 32.60% 31.24% 34.19% 33.75%
Earnings before Interest and Taxes (EBIT)
901 963 772 876 908 93 808 898 1,040 695 638
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,078 1,145 942 1,081 1,083 276 971 1,083 1,246 894 921
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.69 1.76 1.73 1.83 2.04 1.78 1.90 1.80 1.37 1.48 1.42
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
2.91 3.04 2.85 3.01 3.36 2.82 2.99 2.85 2.14 2.27 2.11
Price to Earnings (P/E)
22.14 20.66 19.66 20.77 22.31 30.02 30.87 29.23 21.91 18.15 19.53
Dividend Yield
2.65% 2.53% 2.77% 2.57% 2.33% 2.74% 2.64% 2.78% 3.61% 3.31% 3.49%
Earnings Yield
4.52% 4.84% 5.09% 4.81% 4.48% 3.33% 3.24% 3.42% 4.57% 5.51% 5.12%
Enterprise Value to Invested Capital (EV/IC)
1.48 1.52 1.48 1.55 1.68 1.50 1.58 1.51 1.24 1.31 1.27
Enterprise Value to Revenue (EV/Rev)
3.67 3.82 3.73 3.86 4.20 3.69 3.87 3.72 2.99 3.08 2.92
Enterprise Value to EBITDA (EV/EBITDA)
14.67 14.25 13.50 13.70 14.98 16.76 17.61 17.19 13.50 12.20 11.93
Enterprise Value to EBIT (EV/EBIT)
18.22 17.40 16.28 16.56 18.09 21.39 22.37 21.67 17.01 14.87 15.10
Enterprise Value to NOPAT (EV/NOPAT)
23.05 22.41 21.10 21.79 23.89 29.05 30.09 29.05 22.98 18.50 18.21
Enterprise Value to Operating Cash Flow (EV/OCF)
30.56 42.59 41.47 35.93 38.19 25.54 25.63 27.71 22.69 25.70 23.95
Enterprise Value to Free Cash Flow (EV/FCFF)
36.09 65.12 53.92 36.54 46.50 37.79 36.21 66.16 50.88 34.65 26.05
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.50 0.51 0.00 0.60 0.60 0.64 0.65 0.64 0.62 0.63 0.77
Long-Term Debt to Equity
0.39 0.39 0.00 0.50 0.50 0.53 0.49 0.56 0.53 0.51 0.62
Financial Leverage
0.43 0.43 1.94 0.48 0.48 0.50 2.10 0.54 0.53 0.54 0.33
Leverage Ratio
2.05 2.05 4.14 2.08 2.08 2.11 4.34 2.15 2.13 2.19 2.19
Compound Leverage Factor
1.51 1.91 3.19 1.60 1.83 -3.50 3.54 1.72 1.75 1.44 1.22
Debt to Total Capital
33.43% 33.94% 100.00% 37.46% 37.35% 39.08% 39.45% 38.88% 38.44% 38.75% 43.35%
Short-Term Debt to Total Capital
7.34% 8.35% 12.86% 6.07% 6.20% 6.64% 9.91% 4.83% 5.55% 7.45% 8.12%
Long-Term Debt to Total Capital
26.09% 25.59% 87.14% 31.39% 31.15% 32.44% 29.54% 34.05% 32.89% 31.29% 35.23%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 14.06%
Common Equity to Total Capital
66.57% 66.06% 166.16% 62.54% 62.65% 60.92% 60.55% 61.12% 61.56% 61.25% 42.60%
Debt to EBITDA
3.45 3.32 3.60 3.49 3.50 4.60 4.67 4.66 4.42 3.85 6.21
Net Debt to EBITDA
3.02 2.90 3.17 3.04 3.02 3.97 3.99 4.03 3.81 3.20 1.28
Long-Term Debt to EBITDA
2.70 2.50 3.13 2.92 2.92 3.82 3.50 4.08 3.78 3.11 5.04
Debt to NOPAT
5.43 5.22 5.62 5.54 5.59 7.97 7.98 7.87 7.53 5.84 9.48
Net Debt to NOPAT
4.75 4.57 4.96 4.83 4.82 6.88 6.83 6.82 6.49 4.86 1.95
Long-Term Debt to NOPAT
4.23 3.94 4.90 4.65 4.66 6.62 5.98 6.89 6.44 4.71 7.70
Altman Z-Score
1.31 1.36 1.31 1.37 1.50 1.22 1.31 1.34 1.15 1.17 1.13
Noncontrolling Interest Sharing Ratio
0.00% 0.00% -98.22% 0.00% 0.00% 0.00% -100.84% 0.00% 0.00% 0.00% 14.36%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.39 0.38 0.51 0.51 0.53 0.49 0.47 0.64 0.62 0.64 2.31
Quick Ratio
0.17 0.18 0.23 0.24 0.26 0.25 0.22 0.28 0.27 0.33 0.24
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-149 -929 -1,022 -418 -603 -407 290 -449 -379 -608 -244
Operating Cash Flow to CapEx
479.34% 192.86% 53.80% 576.32% 502.40% 524.07% 195.33% 406.60% 575.68% 481.08% 289.69%
Free Cash Flow to Firm to Interest Expense
-0.63 0.00 -5.74 -2.05 -5.69 0.00 1.96 -2.49 -2.02 0.00 -0.87
Operating Cash Flow to Interest Expense
2.45 0.00 0.48 3.22 5.92 0.00 1.41 2.39 3.40 0.00 1.00
Operating Cash Flow Less CapEx to Interest Expense
1.94 0.00 -0.41 2.66 4.75 0.00 0.69 1.81 2.81 0.00 0.65
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.29 0.29 0.29 0.29 0.29 0.29 0.29 0.30 0.30 0.31 0.27
Accounts Receivable Turnover
10.72 10.39 10.81 11.15 11.11 10.70 11.76 10.91 10.98 10.47 11.82
Inventory Turnover
4.92 5.48 5.13 5.05 4.97 5.59 5.06 4.75 4.59 5.02 4.65
Fixed Asset Turnover
5.89 5.71 5.77 5.83 5.69 5.42 5.50 5.55 5.55 5.36 5.47
Accounts Payable Turnover
1.46 1.53 1.64 1.73 1.86 2.07 2.19 2.29 2.39 2.54 2.61
Days Sales Outstanding (DSO)
34.04 35.14 33.76 32.73 32.85 34.12 31.05 33.45 33.23 34.88 30.89
Days Inventory Outstanding (DIO)
74.14 66.56 71.18 72.29 73.39 65.30 72.09 76.91 79.59 72.77 78.48
Days Payable Outstanding (DPO)
249.45 238.57 223.13 211.16 196.39 176.08 166.65 159.63 152.79 143.55 139.74
Cash Conversion Cycle (CCC)
-141.28 -136.88 -118.18 -106.14 -90.15 -76.66 -63.51 -49.27 -39.97 -35.90 -30.37
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
36,506 37,213 37,735 37,617 37,802 37,664 38,072 38,750 38,954 38,953 38,888
Invested Capital Turnover
0.41 0.41 0.40 0.41 0.41 0.41 0.41 0.41 0.42 0.43 0.44
Increase / (Decrease) in Invested Capital
848 1,656 1,607 1,078 1,296 451 337 1,133 1,152 1,289 816
Enterprise Value (EV)
54,117 56,600 55,699 58,175 63,659 56,675 60,053 58,666 48,284 51,178 49,401
Market Capitalization
42,975 45,063 42,617 45,276 50,826 43,254 46,428 44,901 34,654 37,741 35,774
Book Value per Share
$18.15 $18.36 $17.86 $18.23 $18.41 $17.87 $18.02 $18.40 $18.64 $18.78 $18.60
Tangible Book Value per Share
($12.87) ($12.74) ($13.59) ($13.63) ($13.41) ($14.33) ($14.17) ($14.05) ($13.74) ($13.58) ($13.69)
Total Capital
38,102 38,867 14,837 39,523 39,854 39,797 40,373 40,881 41,140 41,657 59,307
Total Debt
12,738 13,191 14,837 14,805 14,885 15,554 15,926 15,896 15,816 16,141 25,707
Total Long-Term Debt
9,940 9,945 12,929 12,406 12,413 12,912 11,927 13,920 13,531 13,036 20,891
Net Debt
11,142 11,537 13,082 12,899 12,833 13,421 13,625 13,765 13,630 13,437 5,288
Capital Expenditures (CapEx)
121 154 158 114 125 162 107 106 111 148 97
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-2,870 -2,562 -1,846 -1,729 -1,685 -2,038 -1,559 -1,204 -1,110 -963 -793
Debt-free Net Working Capital (DFNWC)
-2,610 -2,295 -1,529 -1,291 -1,125 -1,448 -826 -639 -541 81 17,923
Net Working Capital (NWC)
-5,408 -5,541 -3,437 -3,690 -3,597 -4,090 -4,825 -2,615 -2,826 -3,024 13,107
Net Nonoperating Expense (NNE)
181 34 131 145 77 188 110 137 111 328 302
Net Nonoperating Obligations (NNO)
11,142 11,537 37,735 12,899 12,833 13,421 13,625 13,765 13,630 13,437 5,288
Total Depreciation and Amortization (D&A)
177 182 170 205 175 183 163 185 206 199 283
Debt-free, Cash-free Net Working Capital to Revenue
-19.46% -17.29% -12.37% -11.48% -11.12% -13.28% -10.05% -7.64% -6.86% -5.80% -4.68%
Debt-free Net Working Capital to Revenue
-17.69% -15.49% -10.24% -8.57% -7.43% -9.43% -5.32% -4.05% -3.34% 0.49% 105.78%
Net Working Capital to Revenue
-36.66% -37.40% -23.02% -24.50% -23.75% -26.64% -31.09% -16.59% -17.47% -18.21% 77.35%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.37 $0.50 $0.33 $0.38 $0.45 ($0.10) $0.38 $0.40 $0.49 $0.26 $0.20
Adjusted Weighted Average Basic Shares Outstanding
1.40B 1.40B 1.38B 1.36B 1.36B 1.36B 1.36B 1.36B 1.36B 1.36B 1.36B
Adjusted Diluted Earnings per Share
$0.37 $0.49 $0.33 $0.38 $0.45 ($0.11) $0.38 $0.40 $0.49 $0.26 $0.20
Adjusted Weighted Average Diluted Shares Outstanding
1.41B 1.41B 1.39B 1.36B 1.36B 1.37B 1.36B 1.36B 1.36B 1.36B 1.36B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.40B 1.39B 1.36B 1.36B 1.36B 1.36B 1.36B 1.36B 1.36B 1.36B 1.36B
Normalized Net Operating Profit after Tax (NOPAT)
701 727 585 660 693 44 627 684 773 681 572
Normalized NOPAT Margin
18.41% 18.80% 16.86% 16.82% 17.81% 1.08% 17.26% 16.43% 17.95% 15.13% 14.38%
Pre Tax Income Margin
17.45% 23.25% 17.13% 17.13% 20.61% -3.78% 18.16% 17.25% 19.79% 10.16% 8.98%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
3.80 0.00 4.34 4.29 8.57 0.00 5.46 4.99 5.53 0.00 2.27
NOPAT to Interest Expense
2.95 0.00 3.28 3.23 6.54 0.00 4.24 3.80 4.11 0.00 2.03
EBIT Less CapEx to Interest Expense
3.29 0.00 3.45 3.74 7.39 0.00 4.74 4.40 4.94 0.00 1.93
NOPAT Less CapEx to Interest Expense
2.44 0.00 2.40 2.68 5.36 0.00 3.52 3.21 3.52 0.00 1.69
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
58.01% 52.36% 53.51% 53.67% 51.93% 82.86% 80.25% 79.95% 78.89% 60.13% 68.23%
Augmented Payout Ratio
96.55% 84.73% 126.38% 115.78% 111.37% 159.89% 80.59% 80.86% 79.77% 60.56% 68.23%

Financials Breakdown Chart

Key Financial Trends

Note: The dataset provided appears to reflect Keurig Dr Pepper Inc. (ticker: KDP), which is the successor to Dr Pepper Snapple Group (DPS) after the 2018 merger. DPS investors should view these figures as representing the legacy DPS business within the current KDP structure. Below is a concise, four-year trend view based on the quarterly income statements, cash flow statements, and balance sheets in the data, focusing on the latest four years of results (through Q4 2025).

  • Strong fourth-quarter 2025 revenue and solid gross margin. Q4 2025 revenue was $4.499 billion, up from $4.07 billion in Q4 2024 and notably higher than earlier years, with a gross margin around the mid-50s (about 53.8% in Q4 2025: Gross Profit $2.419B / Revenue $4.499B).
  • Consistent quarterly profitability with near-annual operating leverage. Q3 2025 shows about $0.995 billion in operating income, and Q4 2025 remains strong at about $0.881 billion. This indicates sustained, if not growing, operating profitability across core product lines in 2025.
  • Meaningful year-to-date earnings momentum in mid-2025. Net income attributable to common shareholders rose through 2025’s early quarters (Q1 2025 about $0.517B; Q2 2025 about $0.547B; Q3 2025 about $0.662B), signaling improving quarterly earnings through the first three quarters of 2025 (even though Q4 2025 dipped).
  • Positive operating cash flow and healthy free cash flow potential in Q4 2025. Net cash from continuing operating activities in Q4 2025 was $712 million, with capital expenditures around $148 million, implying roughly $564 million of free cash flow for the quarter; similar positive cash-generation patterns appear in the prior 2025 quarters (Q3: $639M OCF; Q2: $431M; Q1: $353M).
  • Solid balance sheet liquidity and a durable equity base. By Q3 2025, total assets were about $54.6 billion and total equity around $25.3 billion, with long-term debt near $13.9 billion and total liabilities around $29.3 billion. This suggests a stable financial position with manageable leverage given scale.
  • Regular cash returns to shareholders. Per-share cash dividends were reported near $0.23 in several quarters (e.g., Q1 2025 and Q2 2025), indicating ongoing discipline of returning cash to investors alongside earnings.
  • Stable earnings framework supported by robust gross margins and revenue mix. Across the last four years, gross margins have generally sat in the mid-50% range, reflecting a steady product mix and pricing power within a mature beverage portfolio.
  • Rising goodwill and intangible asset levels. Goodwill around $20–21B and intangible assets in the mid-$20B range are prominent on the balance sheets (notably in Q3 2025). This reflects prior acquisitions and branding investments, which could be sources of future impairment risk if growth slows or market conditions shift.
  • Ongoing acquisition-related asset growth and noncurrent assets. The composition shifts toward higher noncurrent assets (goodwill, intangibles, long-term investments), indicating continued strategic investments that may affect future depreciation or impairment dynamics.
  • Quarterly volatility in other income/expense dampens pretax results in some periods. Total Other Income/Expense, net shows notable negative values in some quarters (e.g., Q4 2025: -$424 million; Q3 2025: -$143 million), which reduces pretax income in those quarters and can create earnings volatility from period to period.
  • Financing outflows and debt repayments have periodically pressured cash flow. Net cash from financing activities and related debt-repayment items show sizable quarterly outflows (e.g., Q2 2025 saw substantial debt repayments; Q4 2025 also includes debt repayments), which can temper free cash flow after capex and could impact liquidity if sustained at higher levels.
05/19/26 04:47 AM ETAI Generated. May Contain Errors.

Keurig Dr Pepper Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Keurig Dr Pepper's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Keurig Dr Pepper's net income appears to be on an upward trend, with a most recent value of $2.08 billion in 2025, rising from $764 million in 2015. The previous period was $1.44 billion in 2024. View Keurig Dr Pepper's forecast to see where analysts expect Keurig Dr Pepper to go next.

Keurig Dr Pepper's total operating income in 2025 was $3.58 billion, based on the following breakdown:
  • Total Gross Profit: $9.00 billion
  • Total Operating Expenses: $5.42 billion

Over the last 10 years, Keurig Dr Pepper's total revenue changed from $6.28 billion in 2015 to $16.60 billion in 2025, a change of 164.3%.

Keurig Dr Pepper's total liabilities were at $29.94 billion at the end of 2025, a 2.6% increase from 2024, and a 347.8% increase since 2015.

In the past 10 years, Keurig Dr Pepper's cash and equivalents has ranged from $75 million in 2019 to $1.79 billion in 2016, and is currently $1.03 billion as of their latest financial filing in 2025.

Over the last 10 years, Keurig Dr Pepper's book value per share changed from 11.56 in 2015 to 18.78 in 2025, a change of 62.5%.



Financial statements for NASDAQ:KDP last updated on 4/28/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners